[{"data":1,"prerenderedAt":325},["ShallowReactive",2],{"slug-big-pharma-summary":3},{"post":4,"relatedPosts":181,"relatedBooks":324},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":34,"project_category":42,"contact_email_category":47,"yst_prominent_words":48,"class_list":62,"better_featured_image":83,"acf":117,"yoast_meta":125,"_links":128},36821,"2021-11-11T11:58:00","2021-11-11T10:58:00",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=36821&_wpnonce=35a46e7383&status=auto-draft&type=post","2021-11-12T14:59:03","2021-11-12T13:59:03","big-pharma-summary","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-summary",{"rendered":17},"World’s Biggest Pharma Companies Go Digital – Summary",{"rendered":19,"protected":20},"\n\u003Cp>\u003Cstrong>In recent weeks, we have examined more than two dozen of the largest pharma companies from the perspective of how they use digital solutions and what digital health investments they make. These pharmaceutical giants have long-term strategies that, when the time comes, will alter our lives entirely. So it is critical that we know where they stand and how they imagine our common future – for it will become our reality.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>Related articles\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\">Big Pharma, Big Money: Johnson&Johnson, Pfizer, Bayer, Novartis in digital health\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-2\">Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s Extending Digital Health Reaches\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-3\">Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">The common grounds\u003C\u002Fh3>\n\n\n\n\u003Cp>Our research on the 14 most important pharma companies that have digital solutions brought four issues to the spotlight that are at the focal point of their development. One is how they relate to patients through digital therapeutics, and the other is how they cooperate with technology companies in order to become more successful in the market. \u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">1. \u003Cstrong>Digital therapeutics\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>We clearly need to begin with \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Digital Therapeutics\u003C\u002Fa> (Dtx). It stands out in its importance as pharmaceutical companies see this as a new technology capable of altering their approach to patients and customers. Digital therapeutics (Dtx) as the Digital Therapeutics Alliance explains, “\u003Cem>deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders.” \u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>Pharmaceutical companies see this as new technology that could possibly be particularly beneficial for them. The concept is that a digital healthcare technology (whether an application, sensor, process or even service) is combined with an existing drug, adding real value to the patients; but it also means that the technology itself can be used as medicine. This is a strange and unfamiliar approach pharma companies need to get used to, but they see that it’s exciting and has business potential.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>2. How to cooperate with Big Tech\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>All in all, I have the feeling that pharma giants have a blurred vision of how they could and should cooperate with tech companies. It is evident that tech companies have the ability to create tools and solutions people would actually want to use. Pharma has not yet crossed that barrier, probably that is why compliance stands at around fifty percent worldwide, not 90%.\u003C\u002Fp>\n\n\n\n\u003Cp>On the other hand, tech companies want to explode into the healthcare business and feast on its financial benefits; they need a door inside with a guide. I see the future in the actual collaboration between pharma and big tech: technological companies provide technologies that people like, can use and appreciate; and drug makers add their knowledge and content, experience and evidence-based background.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">3. \u003Cstrong>Based on evidence\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>We see a lot of investments in companies that are active in health tech. However, despite the fact that 2020 was a record-setting year in terms of healthcare investments, Q1 of 2021 \u003Ca href=\"https:\u002F\u002Fwww.svb.com\u002Ftrends-insights\u002Freports\u002Fhealthcare-investments-and-exits\u002F2021-midyear#:~:text=Q1%202021%20spiked%20to%20a,double%202020's%20first%20half%20pace.\" target=\"_blank\" rel=\"noreferrer noopener\">spiked to a record $23.4B\u003C\u002Fa>, beating Q3 2020’s quarterly results by 56%, it is important to realise that these investment announcements do not necessarily correlate to actual evidence-based results. These investments usually span from 1 to 3 years, but our main question is that we seldom read about actual results.\u003C\u002Fp>\n\n\n\n\u003Cp>We collected our thoughts about the quality and promise of digital health and A.I. start-ups and technologies in our e-book, \u003Ca href=\"https:\u002F\u002Fleanpub.com\u002Fdigital-health-investments\">Invest In Digital Health – The \u003C\u002Fa>\u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fleanpub.com\u002Fdigital-health-investments\" target=\"_blank\">Medical\u003C\u002Fa>\u003Ca href=\"https:\u002F\u002Fleanpub.com\u002Fdigital-health-investments\"> Futurist’s Guide\u003C\u002Fa>. In it, we focused on answering questions like how we make a decision whether to feature a report or announcement on our channels; or how we tend to make sense of all the changes around healthcare when it comes to investments. We included 24 technological trends we find the most promising by also highlighting some specific areas that are worth following.\u003C\u002Fp>\n\n\n\u003Cdiv class=\"ebook-block-spacer\">\u003C\u002Fdiv>\n\u003Cdiv class=\"ebook-block-backdrop backdrop-blur\" id=\"modal-backdrop-ebook-block_618d1452eb32c\">\u003C\u002Fdiv>\n\u003Cinput style=\"display: none\" id=\"modal-ebook-block_618d1452eb32c\"\n       value=\"{"featured":{"ID":31417,"post_author":"6","post_date":"2020-12-02 08:54:13","post_date_gmt":"2020-12-02 07:54:13","post_content":"<!-- wp:paragraph -->\\n<p>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it's a good time to invest in Digital Health and give recommendations on where to invest by looking at the top 24 technological trends we find the most promising.<\\\u002Fp>\\n<!-- \\\u002Fwp:paragraph -->","post_title":"Invest In Digital Health - The Medical Futurist's Guide","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"invest-in-digital-health","to_ping":"","pinged":"","post_modified":"2023-03-12 18:17:41","post_modified_gmt":"2023-03-12 17:17:41","post_content_filtered":"","post_parent":0,"guid":"https:\\\u002F\\\u002Fapi.medicalfuturist.com\\\u002F?post_type=book&p=31417","menu_order":9,"post_type":"book","post_mime_type":"","comment_count":"0","filter":"raw","featured_image":["https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002Finvest-in-digital-health.png",320,413,false],"leanpub_url":"https:\\\u002F\\\u002Fleanpub.com\\\u002Fdigital-health-investments","preview":[{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-1-1.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-2.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-3.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-4.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-5.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-6.png"},{"image":"https:\\\u002F\\\u002Fcdn.medicalfuturist.com\\\u002Fwp-content\\\u002Fuploads\\\u002F2020\\\u002F12\\\u002FInvest-In-Digital-Health-Guide-Preview-7.png"}],"buy_button_text":"Get it on Leanpub"},"others":[]}\"\u002F>\n\u003Cdiv id=\"ebook-block_618d1452eb32c\" class=\"ebook\">\n    \u003Cdiv class=\"ebook-block h-100\">\n        \u003Cdiv class=\"container h-100\">\n            \u003Cdiv class=\"article-body h-100\">\n                \u003Cdiv class=\"row h-100 align-items-center\">\n                    \u003Cdiv class=\"col-md-5 pr-md-5 mb-4 mb-md-0\">\n                        \u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F12\u002Finvest-in-digital-health.png\" alt=\"\" class=\"img-fluid\">\n                    \u003C\u002Fdiv>\n                    \u003Cdiv class=\"col-md-7 pl-md-3\">\n                        \u003Ch3>Invest In Digital Health – The Medical Futurist’s Guide\u003C\u002Fh3>\n                        \u003C!-- wp:paragraph -->\n\u003Cp>Artificial Intelligence and Digital Health are booming. In this book, we explain why now it’s a good time to invest in Digital Health and give recommendations on where to invest by looking at the top 24 technological trends we find the most promising.\u003C\u002Fp>\n\u003C!-- \u002Fwp:paragraph -->                        \u003Cbutton data-target=\"modal-ebook-block_618d1452eb32c\"\n                                class=\"ebook-block-button btn btn-lg font-weight-bold btn-tmf-blue mt-3\">\n                            Start Reading Now\n                        \u003C\u002Fbutton>\n                    \u003C\u002Fdiv>\n                \u003C\u002Fdiv>\n            \u003C\u002Fdiv>\n        \u003C\u002Fdiv>\n    \u003C\u002Fdiv>\n\u003C\u002Fdiv>\n\n\n\n\u003Cp>Pharmaceutical companies, therefore, have a lot of mistrust and cynicism towards such tech inventions. Due to the ordinances of evidence-based medicine, it takes a long time even for good technologies to gain entry into medicine and healing on a practical level. This dithering brings about business risks, making pharma companies more hesitant to invest in such technologies. \u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">4. \u003Cstrong>From patient-centricity to patient design\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cp>Putting patients into the centre of care is an attractive buzzword for all. It became an industry-wide approach in principle, however, we don’t yet see the concept implemented more deeply into pharma projects to be used in practice.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"Why is Patient Design Essential in Healthcare? \u002F Episode 6 - The Medical Futurist\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FhjPcpVaJ9xU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Cp>I need to repeat it again: we encourage every organization, from the CDC to the WHO, every health insurer, pharma company and government to appoint a patient advisory board so they can all include patients into their concept, gain invaluable insights and embrace patient design on the deepest levels of decision-making.\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">Summary\u003C\u002Fh3>\n\n\n\n\u003Ch5 class=\"wp-block-heading\">\u003Cstrong>Looking at these 14 companies we investigated on their digital health activities, we can draw the conclusion that none of them has an advanced, overarching digital strategy we thought they’d do. But this comes out of reason: by moving forward on niche areas in digital technology they have more chance for success altogether.\u003C\u002Fstrong>\u003C\u002Fh5>\n\n\n\n\u003Ch5 class=\"wp-block-heading\">\u003Cstrong>This is a very similar concept to Big Tech’s approach to healthcare; minimising risks and keeping investments under control and betting on certain directions that have the chance to be more profitable.\u003C\u002Fstrong>\u003C\u002Fh5>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n",false,{"rendered":22,"protected":20},"\u003Cp>In recent weeks, we have examined more than two dozen of the largest pharma companies from the perspective of how they use digital solutions and what digital health investments they do.\u003C\u002Fp>\n",6,36791,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32,33],6261,521,490,[35,36,37,38,39,40,41],7339,7341,7385,7461,1440,6203,313,[43,44,45,46],947,950,951,952,[],[49,50,51,52,53,54,55,56,57,58,59,60,61],1611,1613,1617,1631,1681,1883,2343,1571,5139,1577,6067,1595,1609,[63,14,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82],"post-36821","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-forecast","category-future-medicine","category-future-of-pharma","tag-dtx","tag-digital-therapeutics","tag-big-pharma","tag-evidence","tag-investment","tag-big-tech","tag-medicine","project_category-company","project_category-medical-professionals","project_category-patients","project_category-policy-makers",{"id":24,"alt_text":84,"caption":27,"description":85,"media_type":86,"media_details":87,"post":115,"source_url":116},"drug, drug design, pharma","Big Pharma And Digital Health, Drug design\n","image",{"width":88,"height":89,"file":90,"sizes":91,"image_meta":113},1920,1080,"2021\u002F11\u002Ftmf_article_299-01.png",{"medium":92,"large":98,"thumbnail":103,"medium_large":107,"1536x1536":108},{"file":93,"width":94,"height":95,"mime-type":96,"source_url":97},"tmf_article_299-01-370x208.png","370","208","image\u002Fpng","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_299-01-370x208.png",{"file":99,"width":100,"height":101,"mime-type":96,"source_url":102},"tmf_article_299-01-768x432.png","768","432","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_299-01-768x432.png",{"file":104,"width":105,"height":105,"mime-type":96,"source_url":106},"tmf_article_299-01-150x150.png","150","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_299-01-150x150.png",{"file":99,"width":100,"height":101,"mime-type":96,"source_url":102},{"file":109,"width":110,"height":111,"mime-type":96,"source_url":112},"tmf_article_299-01-1536x864.png","1536","864","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_299-01-1536x864.png",{"aperture":114,"credit":27,"camera":27,"caption":27,"created_timestamp":114,"copyright":27,"focal_length":114,"iso":114,"shutter_speed":114,"title":27,"orientation":114},"0",36697,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_299-01.png",{"subtitle":27,"cta_type":118,"cta_color":27,"related_books":119,"related_posts_footer":122,"related_posts":20},"subscribe",[120,121],24764,24757,[123,124,115],36507,36643,{"yoast_wpseo_title":126,"yoast_wpseo_metadesc":127,"yoast_wpseo_canonical":15},"World's Biggest Pharma Companies Go Digital – Summary - The Medical Futurist","In examining more than two dozen of the largest pharma companies from the perspective of how they use digital solutions we now have some conclusions.",{"self":129,"collection":135,"about":138,"author":141,"replies":144,"version-history":147,"predecessor-version":151,"wp:featuredmedia":155,"wp:attachment":158,"wp:term":161,"curies":177},[130],{"href":131,"targetHints":132},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36821",{"allow":133},[134],"GET",[136],{"href":137},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[139],{"href":140},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[142],{"embeddable":26,"href":143},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[145],{"embeddable":26,"href":146},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=36821",[148],{"count":149,"href":150},4,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36821\u002Frevisions",[152],{"id":153,"href":154},36831,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36821\u002Frevisions\u002F36831",[156],{"embeddable":26,"href":157},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36791",[159],{"href":160},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=36821",[162,165,168,171,174],{"taxonomy":163,"embeddable":26,"href":164},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=36821",{"taxonomy":166,"embeddable":26,"href":167},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=36821",{"taxonomy":169,"embeddable":26,"href":170},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=36821",{"taxonomy":172,"embeddable":26,"href":173},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=36821",{"taxonomy":175,"embeddable":26,"href":176},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=36821",[178],{"name":179,"href":180,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[182],{"id":115,"date":183,"date_gmt":184,"guid":185,"modified":187,"modified_gmt":188,"slug":189,"status":13,"type":14,"link":190,"title":191,"content":193,"excerpt":195,"author":197,"featured_media":198,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":199,"categories":200,"tags":204,"project_category":224,"contact_email_category":225,"yst_prominent_words":226,"class_list":229,"better_featured_image":253,"acf":273,"yoast_meta":278,"_links":281},"2021-11-04T10:00:00","2021-11-04T09:00:00",{"rendered":186},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=36697&_wpnonce=3c32e44344&status=auto-draft&type=post","2021-11-05T00:47:49","2021-11-04T23:47:49","big-pharma-part-3","https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-3",{"rendered":192},"Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche",{"rendered":194,"protected":20},"\n\u003Cp>\u003Cstrong>With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And to have a better picture of where those interests lie, it is worth taking a look at what moves pharma giants are making in this sphere. With this in mind, we started a series of articles focusing on the digital health efforts of 14 global pharma companies. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>The \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\">first article\u003C\u002Fa> explored developments coming from Johnson & Johnson, Pfizer, Bayer and Novartis, while the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-2\u002F\" target=\"_blank\">second article\u003C\u002Fa> investigated those coming from Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb. This third article, which will conclude the series, will peek into the digital health trends that pharma giants Boehringer Ingelheim, Takeda, AstraZeneca, Amgen and Roche have taken an interest in.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Boehringer Ingelheim: leaning on the patient side of the equation\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>To boost opportunities for innovators and digital health tech uptake in the UK, pharma giant Boehringer Ingelheim (BI) \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdigitalhealth.london\u002Fbi-launches-new-guide-to-help-unlock-nhs-for-innovators-and-accelerate-uptake-of-digital-health-tech\" target=\"_blank\">launched a new guide\u003C\u002Fa> in December 2020. It provides entrepreneurs with insights into the NHS, as well as potential pathways to sustainably improve the health system’s services with emerging technologies.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-768x432.png\" alt=\"digital health investors\" class=\"wp-image-24505\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>BI has also made moves to improve the patient side of the digital health equation. Like its counterparts \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Pfizer\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-2\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Bristol Myers Squibb\u003C\u002Fa>, BI has developed a liking for \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\" target=\"_blank\" rel=\"noreferrer noopener\">digital therapeutics (DTx)\u003C\u002Fa>. In September 2020, the pharma company signed \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fboehringer-ingelheim-click-therapeutics-ink-500m-digital-therapeutics-development\" target=\"_blank\" rel=\"noreferrer noopener\">a $500 million deal with Click Therapeutics\u003C\u002Fa> for the development of a DTx solution for patients with schizophrenia. The software will help patients in adjusting their behaviour by leveraging cognitive and neurobehavioral mechanisms. \u003C\u002Fp>\n\n\n\n\u003Cp>The following month, it \u003Ca href=\"https:\u002F\u002Fpharmaphorum.com\u002Fnews\u002Fboehringer-yale-trial-digital-tech-in-heart-failure\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">partnered with Yale University\u003C\u002Fa> on a new trial involving a digital health technology. The latter, a smart bathroom scale, integrates cardiac monitoring and a companion app to help cardiac patients better manage their condition and improve their prospects. \u003C\u002Fp>\n\n\n\n\u003Cp>And this September, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fpharmaphorum.com\u002Fnews\u002Fcoalition-formed-to-represent-patient-interests-in-digital-health\u002F\" target=\"_blank\">sponsored a new coalition\u003C\u002Fa>, the Patient Coalition for AI, Data and Digital Tech in Health. It aims to ensure that patients can access digital health services equitably.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Takeda: pushing for digital health innovation\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Considering Japanese multinational pharmaceutical company Takeda’s recent moves, the big fish seems to incentivise innovative projects that can improve the healthcare ecosystem. \u003C\u002Fp>\n\n\n\n\u003Cp>This March, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.shine.cn\u002Fbiz\u002Fcompany\u002F2103226334\u002F\" target=\"_blank\">launched TakedaSpark\u003C\u002Fa>, an incubation platform, in Shanghai. Through TakedaSpark, Takeda aims to boost digital health innovation through new projects and partnerships.\u003Cem> “We hope to use flexible, innovative and high-quality products to provide better treatments for patients,”\u003C\u002Fem> \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.shine.cn\u002Fbiz\u002Fcompany\u002F2103226334\u002F\" target=\"_blank\">said Sean Shan\u003C\u002Fa>, president of Takeda China. \u003Cem>“Digitalisation will be an empowering tool to expedite our overall efficiency, and it’s also crucial for how we connect with various stakeholders and collaborators.”\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>In line with such efforts, Takeda also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Froundup-orcha-calls-developers-create-apps-long-covid-airflow-simulation-technology\" target=\"_blank\">held its Digital Health Innovation Challenge\u003C\u002Fa> earlier this year. Winners of the challenge are able to partner with the pharma company, and also benefit from funding to help commercialise their projects. One of this year’s winners, IDUN Technologies, focuses on sleep disorders. It \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.venturelab.swiss\u002FIDUN-Technologies-wins-the-Takeda-Digital-Health-Innovation-Challenge-to-further-enable-the-Internet-of-Humans\" target=\"_blank\">develops headphones\u003C\u002Fa> to monitor and promote sleep onset through neuromodulation.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-768x432.png\" alt=\"SleepOn Go2Sleep review\" class=\"wp-image-22064\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf.png 870w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>AstraZeneca: big pharma and big collabs\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Like Pfizer and Johnson & Johnson, Anglo-Swedish drugmaker AstraZeneca is now closely associated with a COVID-19 vaccine. But \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">like the former companies\u003C\u002Fa>, AstraZeneca is also eyeing digital health opportunities closely. \u003C\u002Fp>\n\n\n\n\u003Cp>To that end, the pharma company has collaborated with several players in the industry lately. Last December, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fastrazeneca-partners-qureai-early-stage-diagnoses-lung-cancer\" target=\"_blank\">partnered with Quire.ai\u003C\u002Fa>, an A.I. solution provider. Through this collaboration, AstraZeneca will focus on applying A.I. solutions in developing markets to detect lung cancer at an early stage, and hence reduce associated mortality rates. \u003C\u002Fp>\n\n\n\n\u003Cp>This April, AstraZeneca \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedcitynews.com\u002F2021\u002F04\u002Fastrazeneca-lands-first-big-partner-for-digital-health-platform\u002F\" target=\"_blank\">announced a collaboration\u003C\u002Fa> with Massachusetts General Hospital. The latter will employ the drugmaker’s digital health platform for heart failure and asthma management in a real-world setting. In the same month, AstraZeneca \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnvidia-partners-astrazeneca-and-university-florida-ai-powered-drug-discovery\" target=\"_blank\">partnered with\u003C\u002Fa> NVIDIA and the University of Florida for a new drug-discovery project. The latter will use the new MegaMoIBART model that leverages NVIDIA’s A.I. drug discovery platform and a new kind of technology called transformer neural networks. According to Kimberly Powell, VP of healthcare at NVIDIA, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnvidia-partners-astrazeneca-and-university-florida-ai-powered-drug-discovery\" target=\"_blank\">transformer neural networks could help\u003C\u002Fa> accelerate research and speed up drug discovery.\u003C\u002Fp>\n\n\n\n\u003Cp>AstraZeneca also announced another partnership in August \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Frenalytix-ai-and-astrazeneca-team-improve-chronic-kidney-disease-outcomes\" target=\"_blank\">with Renalytix AI\u003C\u002Fa>, an A.I.-enabled in vitro diagnostics company. With the latter’s KidneyIntelX platform, the team’s researchers will assign a risk score to chronic kidney disease patients based on their medical records. Physicians can subsequently use this score to determine the progression of the disease and prevent complications. \u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-768x432.jpg\" alt=\"\" class=\"wp-image-28295\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-1536x864.jpg 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image.jpg 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>The pharma giant is also showing some interest in point-of-care devices. In August 2020, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fastrazeneca-taps-eko-heart-screening-initiative\" target=\"_blank\">teamed up with Eko\u003C\u002Fa> to use the latter’s digital health tools in clinical trials. Eko is itself known for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbridge-tradition-innovation-eko-core-digital-stethoscope-review\u002F\" target=\"_blank\">developing smart digital stethoscopes\u003C\u002Fa>. AstraZeneca announced \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fastrazeneca-taps-alivecor-kidney-focused-collaboration\" target=\"_blank\">another similar partnership with AliveCor\u003C\u002Fa> this February. With the latter’s A.I.-enabled personal ECG devices and algorithms, the team will study new methods, non-invasive methods to manage cardiac and renal issues.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Amgen: small steps\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>For American multinational biopharmaceutical company Amgen, collaborations are also key to its digital health ventures. While it has not been as aggressive in this regard as its competitors, in April, Amgen announced two new digital health collaborations.\u003C\u002Fp>\n\n\n\n\u003Cp>It partnered \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fliva-healthcare-and-amgen-partner-improve-access-cardiac-rehabilitation\" target=\"_blank\">with Liva Healthcare\u003C\u002Fa>, a digital health coaching company, to develop a tele-rehabilitation solution for cardiac patients. More specifically, it is targeted to help patients gauge and adjust their lifestyle following a heart attack.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-768x432.png\" alt=\"Can telepsychology work?\" class=\"wp-image-30867\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Amgen also launched \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.firstwordpharma.com\u002Fnode\u002F1818618\" target=\"_blank\">a new digital health study with Datos Health\u003C\u002Fa> in April. From patient data collected remotely through digital technologies, they will study the feasibility of improving heart failure treatment with better and personalised guidelines. \u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Roche: leveraging its digital health acquisition\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Swiss heavyweight Roche was explicit about its interest in digital health solutions \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-health-mergers-and-acquisitions-2018\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">relatively early on\u003C\u002Fa>. In 2017, it \u003Ca href=\"https:\u002F\u002Fwww.roche.com\u002Fmedia\u002Freleases\u002Fmed-cor-2017-06-30.htm\" target=\"_blank\" rel=\"noreferrer noopener\">acquired diabetes management start-up mySugr\u003C\u002Fa>, and integrated the app to Roche’s own devices. It maintained its interest in investigating digital health tools in diabetes management in subsequent years and leveraged this key acquisition. \u003C\u002Fp>\n\n\n\n\u003Cp>In April 2021, Roche \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froches-new-mysugar-feature-lets-users-control-their-insulin-pump-virtually\" target=\"_blank\">integrated mySugr’s Logbook\u003C\u002Fa> with Nordisk’s connected insulin pens, providing patients with more insights into managing their condition. In May, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froches-new-mysugar-feature-lets-users-control-their-insulin-pump-virtually\" target=\"_blank\">added the new Pump Control module\u003C\u002Fa> to the mySugr app. It allows users to deliver a standard bolus remotely with their Accu-Chek Insight insulin pump. The latter device was also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froche-inks-deal-diabeloop-integrate-automated-insulin-delivery\" target=\"_blank\">able to integrate with the Diabeloop monitoring system\u003C\u002Fa> following a new partnership by Roche in March. The system’s algorithm continuously monitors and can adjust insulin delivery.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-768x432.jpg\" alt=\"diabetes technology\" class=\"wp-image-24563\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-512x288.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: www.bloomberg.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Roche’s recent moves seem invested in healthcare A.I. In September, it inked a deal \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fmedial-earlysign-signs-deal-roche-develop-ai-enabled-cancer-detection-tool\" target=\"_blank\">with Israeli startup Medial EarlySign\u003C\u002Fa> to bring an A.I.-powered early-stage gastric cancer detection tool. Roche also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.digitalhealthglobal.com\u002Fpatchai-and-roche-signed-a-deal-for-a-digital-health-solution-in-oncology\u002F\" target=\"_blank\">paired with PatchAi\u003C\u002Fa> to develop a cancer patient support software that uses A.I. to engage users in empathic conversations.\u003C\u002Fp>\n\n\n\n\u003Cp>Regarding empathy, Roche Diagnostics India \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fasia\u002Froche-diagnostics-india-develops-wellness-app-healthcare-workers\" target=\"_blank\" rel=\"noreferrer noopener\">launched a dedicated app\u003C\u002Fa> in June to assist in the wellness of healthcare workers amid the COVID-19 pandemic. It provides users with self-help and self-assessment tools, as well as counselling sessions.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Staying relevant in the digital health era\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>As we come to a close to our series of articles contemplating the digital health endeavours of pharmaceutical giants, we hope the insights collected will prove to be valuable. A common theme among those big pharma companies seems to be the forging of numerous partnerships with industry players. This could indicate a bid to stay relevant in the ever-evolving digital health field. Some companies have also shown promising steps to consider the patient side of things through new studies, patient-centric tools or even advocacy groups.\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Cp>We will further analyse those general trends in a roundup article. But we hope that this series has given you some insights into where the digital health field might be heading and what aspects of this field that some influential companies are eyeing.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó & Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",{"rendered":196,"protected":20},"\u003Cp>With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And […]\u003C\u002Fp>\n",16,36797,{"_acf_changed":20,"footnotes":27},[201,202,203,33],7079,504,798,[205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,35,222,223],7459,7439,631,7441,7443,819,7445,5399,7447,5403,7449,7451,6465,356,7453,402,7455,7457,7437,[43,44,45],[],[52,53,54,227,228,56,61,49,51],2163,5521,[230,14,64,65,66,67,68,231,232,233,71,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,72,251,252,79,80,81],"post-36697","category-tmf","category-artificial-intelligence","category-digital-health-research","tag-patchai","tag-boehringer-ingelheim","tag-patient-empowerment","tag-amgen","tag-digitisation","tag-pharmaceutics","tag-quire-ai","tag-roche","tag-renalytix","tag-mysugr","tag-eko","tag-liva-healthcare","tag-astra-zeneca","tag-pharma-2","tag-datos-health","tag-sleep","tag-pump-control","tag-diabeloop","tag-takeda",{"id":198,"alt_text":27,"caption":27,"description":254,"media_type":86,"media_details":255,"post":115,"source_url":272},"Big Pharma part 3",{"width":88,"height":89,"file":256,"sizes":257,"image_meta":271},"2021\u002F11\u002Ftmf_article_301-01.png",{"medium":258,"large":261,"thumbnail":264,"medium_large":267,"1536x1536":268},{"file":259,"width":94,"height":95,"mime-type":96,"source_url":260},"tmf_article_301-01-370x208.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-370x208.png",{"file":262,"width":100,"height":101,"mime-type":96,"source_url":263},"tmf_article_301-01-768x432.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-768x432.png",{"file":265,"width":105,"height":105,"mime-type":96,"source_url":266},"tmf_article_301-01-150x150.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-150x150.png",{"file":262,"width":100,"height":101,"mime-type":96,"source_url":263},{"file":269,"width":110,"height":111,"mime-type":96,"source_url":270},"tmf_article_301-01-1536x864.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-1536x864.png",{"aperture":114,"credit":27,"camera":27,"caption":27,"created_timestamp":114,"copyright":27,"focal_length":114,"iso":114,"shutter_speed":114,"title":27,"orientation":114},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01.png",{"cta_type":118,"cta_color":27,"subtitle":27,"related_books":274,"related_posts_footer":276,"related_posts":20},[120,275],24763,[123,124,277],35721,{"yoast_wpseo_title":279,"yoast_wpseo_metadesc":280,"yoast_wpseo_canonical":190},"Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche - The Medical Futurist","Pharmaceutical giants have the potential to shape the digital health landscape. In this series we investigated how big pharma prepares for the next level in medicine.",{"self":282,"collection":287,"about":289,"author":291,"replies":294,"version-history":297,"predecessor-version":301,"wp:featuredmedia":305,"wp:attachment":308,"wp:term":311,"curies":322},[283],{"href":284,"targetHints":285},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697",{"allow":286},[134],[288],{"href":137},[290],{"href":140},[292],{"embeddable":26,"href":293},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[295],{"embeddable":26,"href":296},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=36697",[298],{"count":299,"href":300},13,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697\u002Frevisions",[302],{"id":303,"href":304},36795,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697\u002Frevisions\u002F36795",[306],{"embeddable":26,"href":307},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36797",[309],{"href":310},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=36697",[312,314,316,318,320],{"taxonomy":163,"embeddable":26,"href":313},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=36697",{"taxonomy":166,"embeddable":26,"href":315},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=36697",{"taxonomy":169,"embeddable":26,"href":317},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=36697",{"taxonomy":172,"embeddable":26,"href":319},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=36697",{"taxonomy":175,"embeddable":26,"href":321},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=36697",[323],{"name":179,"href":180,"templated":26},[],1788949186960]